Welcome to our dedicated page for Senestech news (Ticker: SNES), a resource for investors and traders seeking the latest updates and insights on Senestech stock.
SenesTech Inc (SNES) provides innovative fertility control solutions for sustainable rodent management through its EPA-registered products. This news hub offers investors and pest control professionals timely updates on corporate developments and scientific advancements in humane pest control technology.
Access official press releases covering product launches, regulatory milestones, and partnership announcements. Our curated collection includes updates on ContraPest deployments, Evolve soft bait applications, and research breakthroughs in integrated pest management strategies.
Discover updates organized by key operational areas: regulatory approvals, distribution expansions, and scientific validation studies. Stay informed about developments in non-lethal pest control solutions that align with global sustainability initiatives and changing environmental regulations.
Bookmark this page for direct access to SenesTech's verified announcements. Monitor progress in biotechnology applications for urban pest management and ecological preservation through our comprehensive news repository.
SenesTech (NASDAQ: SNES), a fertility control solutions provider for animal pest populations, has announced the closing of a warrant exercise transaction that generated $4.4 million in gross proceeds. The transaction involved the exercise of existing warrants to purchase 1,458,872 shares of common stock at $2.90 per share.
As part of the transaction, the company issued new unregistered short-term warrants to purchase an additional 1,458,872 shares at $4.15 per share, with a purchase price of $0.125 per warrant. These new warrants expire 15 months after the effective date of the resale registration statement. If fully exercised, the new warrants could generate approximately $6.0 million in additional gross proceeds. H.C. Wainwright served as the exclusive placement agent for the transaction.
The company plans to use the net proceeds for working capital and general corporate purposes.
SenesTech (NASDAQ: SNES), a fertility control solutions provider for animal pest populations, has announced warrant exercise agreements that will generate $4.4 million in gross proceeds. The transaction involves the immediate exercise of existing warrants to purchase 1,458,872 shares of common stock at $2.90 per share, with an expected closing date of July 1, 2025.
As part of the transaction, SenesTech will issue new unregistered short-term warrants to purchase an additional 1,458,872 shares at $4.15 per share, with a purchase price of $0.125 per warrant. These new warrants will be exercisable immediately and expire fifteen months after the effective date of the resale registration statement. If fully exercised, these new warrants could generate additional gross proceeds of approximately $6.0 million.
The company plans to use the net proceeds for working capital and general corporate purposes. H.C. Wainwright is serving as the exclusive placement agent for the transaction.
SenesTech (NASDAQ: SNES) has reported successful results from major urban deployments of its Evolve™ Rat Birth Control solution in Hong Kong and San Francisco. The company's innovative approach combines fertility control with traditional rodenticide methods, demonstrating significant effectiveness in urban pest control.
In Hong Kong's high-density mixed-use building deployment, the company achieved dramatic reduction in rodent sightings and bait consumption within three months. Similar success was recorded in San Francisco, with notable decreases in rodent activity and new births. SenesTech is now preparing for a container-sized order from Hong Kong following these positive results.
SenesTech (NASDAQ: SNES) has successfully completed a nine-month field trial of Evolve™ Rat Birth Control at UC Irvine's University Hills residential community. The trial, conducted with Irvine Campus Housing Authority (ICHA), demonstrated 98% bait consumption across 267 stations, replacing traditional rodenticides with an eco-friendly solution.
The initiative, which began in September 2024, was driven by resident pressure to adopt safer pest management practices. The project supported the HOOT Group's efforts to promote owl nesting and reduce rodenticide use. Following the successful trial, ICHA is placing a multi-pallet restocking order for continued deployment and expansion.
SenesTech (NASDAQ: SNES), a company specializing in fertility control solutions for rodent population management, has announced its participation in the upcoming Lytham Partners Spring 2025 Investor Conference. The virtual event will take place on May 29, 2025, featuring a webcast fireside chat at 3:30 p.m. ET. The company's management will also be available for one-on-one meetings with investors throughout the conference. Interested participants can access the webcast through the conference website or register for individual meetings with management through Lytham Partners.
SenesTech (NASDAQ: SNES) has announced it will release its first quarter 2025 financial results on Thursday, May 8, 2025, after the market close. The company will host a conference call the same day at 5:00 p.m. Eastern time to discuss the results for the period ended March 31, 2025.
Investors can join the conference call by dialing (844) 308-3351 or (412) 317-5407. A live webcast will be available through the company's Investor Relations website. A teleconference replay will be accessible for seven days, while the webcast replay will remain available for 90 days in the Investor Relations section.